Deltec Asset Management’s Boston Scientific BSX Stock Holding History

Deltec Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.67M	Buy	85,900 +30,500	+55%	+$1.66M	0.54%	37
2026 Q1	$3.48M	Buy	55,400 +13,100	+31%	+$1.05M	0.64%	35
2025 Q4	$4.03M	Sell	42,300 -500	-1%	-$49K	0.67%	35
2025 Q3	$4.18M	Buy	42,800 +14,500	+51%	+$1.5M	0.69%	33
2025 Q2	$3.04M	Buy	28,300 +21,800	+335%	+$2.21M	0.54%	42
2025 Q1	$656K	Buy	+6,500	New	+$655K	0.14%	99
2022 Q1	–	Sell	-7,500	Closed	-$319K	–	266
2021 Q4	$319K	Hold	7,500	–	–	0.05%	200
2021 Q3	$325K	Sell	7,500 -1,000	-12%	-$44.2K	0.05%	222
2021 Q2	$363K	Hold	8,500	–	–	0.05%	229
2021 Q1	$329K	Sell	8,500 -272,410	-97%	-$10.3M	0.05%	234
2020 Q4	$10.1M	Sell	280,910 -6,000	-2%	-$216K	1.55%	14
2020 Q3	$11M	Sell	286,910 -8,000	-3%	-$308K	1.96%	10
2020 Q2	$10.4M	Sell	294,910 -5,000	-2%	-$180K	2.17%	10
2020 Q1	$9.79M	Buy	299,910 +107,710	+56%	+$4.21M	2.71%	10
2019 Q4	$8.69M	Buy	192,200 +116,000	+152%	+$4.85M	1.76%	15
2019 Q3	$3.1M	Hold	76,200	–	–	0.78%	36
2019 Q2	$3.27M	Buy	76,200 +51,200	+205%	+$1.97M	0.72%	38
2019 Q1	$959K	Buy	+25,000	New	+$955K	0.21%	101
2018 Q2	–	Sell	-323,400	Closed	-$8.84M	–	180
2018 Q1	$8.84M	Sell	323,400 -67,100	-17%	-$1.82M	1.76%	15
2017 Q4	$9.68M	Buy	390,500 +129,000	+49%	+$3.56M	1.97%	13
2017 Q3	$7.63M	Sell	261,500 -4,500	-2%	-$124K	1.55%	22
2017 Q2	$7.37M	Sell	266,000 -5,000	-2%	-$133K	1.51%	18
2017 Q1	$6.74M	Sell	271,000 -27,500	-9%	-$669K	1.38%	19
2016 Q4	$6.46M	Buy	+298,500	New	+$6.51M	1.51%	18

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deltec Asset Management's BSX Position: Q2 2026 in Review

Deltec Asset Management increased its Boston Scientific (BSX) stake by 55% in Q2 2026, buying an estimated $1.66M and bringing the position to 85,900 shares worth $3.67M. The position accounts for 0.54% of the portfolio, ranked #37.

Deltec Asset Management first reported a position in BSX in Q4 2016 and has held it in 24 quarters since. The position peaked at $11M in Q3 2020. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Deltec Asset Management held 85,900 shares of Boston Scientific worth $3.67M as of Q2 2026.
Deltec Asset Management bought 30,500 Boston Scientific shares in Q2 2026, an estimated $1.66M.
Boston Scientific made up 0.54% of Deltec Asset Management's portfolio in Q2 2026, its #37 holding.
Deltec Asset Management first reported a position in Boston Scientific in Q4 2016 and has held it in 24 quarters since.
Deltec Asset Management's Boston Scientific position peaked at $11M in Q3 2020.
1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Deltec Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.